Financial results - TEFAS MEDPREVENT SRL

Financial Summary - Tefas Medprevent Srl
Unique identification code: 15481336
Registration number: J12/1451/2003
Nace: 8622
Sales - Ron
21.894
Net Profit - Ron
6.495
Employee
1
The most important financial indicators for the company Tefas Medprevent Srl - Unique Identification Number 15481336: sales in 2023 was 21.894 euro, registering a net profit of 6.495 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Tefas Medprevent Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 16.778 18.515 24.708 31.963 34.768 28.039 23.464 20.822 24.074 21.894
Total Income - EUR 16.900 18.539 24.733 32.400 34.768 28.039 23.464 20.822 24.074 21.894
Total Expenses - EUR 4.353 3.732 3.488 4.469 7.830 5.982 7.332 8.945 8.696 15.184
Gross Profit/Loss - EUR 12.547 14.807 21.245 27.931 26.938 22.057 16.133 11.877 15.378 6.710
Net Profit/Loss - EUR 12.040 14.250 20.503 26.959 25.895 21.215 15.480 11.252 14.778 6.495
Employees 1 1 1 1 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -8.8%, from 24.074 euro in the year 2022, to 21.894 euro in 2023. The Net Profit decreased by -8.238 euro, from 14.778 euro in 2022, to 6.495 in the last year.

Check the financial reports for the company - Tefas Medprevent Srl

Rating financiar

Financial Rating -
Tefas Medprevent Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Tefas Medprevent Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Tefas Medprevent Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Tefas Medprevent Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Tefas Medprevent Srl - CUI 15481336

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 0 0 0 385 76 0 0 0 0 0
Current Assets 18.131 20.664 21.025 32.112 32.475 22.757 17.268 14.628 19.031 10.555
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 1.771 1.100 2.748 6.083 9.326 5.048 3.929 3.892 15.645 5.135
Cash 16.360 19.564 18.277 26.028 23.149 17.709 13.339 10.736 3.386 5.420
Shareholders Funds 17.895 20.154 20.556 27.011 25.946 21.266 15.571 11.341 14.867 6.592
Social Capital 45 45 45 44 43 42 83 81 81 81
Debts 236 510 469 5.485 6.605 1.491 1.696 3.287 4.164 3.962
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 10.555 euro in 2023 which includes Inventories of 0 euro, Receivables of 5.135 euro and cash availability of 5.420 euro.
The company's Equity was valued at 6.592 euro, while total Liabilities amounted to 3.962 euro. Equity decreased by -8.230 euro, from 14.867 euro in 2022, to 6.592 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Tefas Medprevent Srl

Comments - Tefas Medprevent Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.